Clinical use of Lanreotide AG as initial therapy in patients with advanced, non-resectable well (G1) and moderate (G2) differentiated pancreatic neuroendocrine neoplasms (p-NEN) Meeting Abstract
| Authors: | Cwikla, J.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Palucki, J.; Roszkowska-Purska, K.; Kidd, M.; Bodei, L.; Modlin, I. |
| Abstract Title: | Clinical use of Lanreotide AG as initial therapy in patients with advanced, non-resectable well (G1) and moderate (G2) differentiated pancreatic neuroendocrine neoplasms (p-NEN) |
| Meeting Title: | 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease |
| Keywords: | advance; lanreotide; non-resectable pancreatic neuroendocrine neoplams; ag systemic therapy |
| Journal Title: | Neuroendocrinology |
| Volume: | 106 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Mar 7-9 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0028-3835 |
| Publisher: | S. Karger AG |
| Date Published: | 2018-03-01 |
| Start Page: | 187 |
| Language: | English |
| ACCESSION: | WOS:000427285300185 |
| PROVIDER: | wos |
| DOI: | 10.1159/000487699 |
| Notes: | Meeting Abstract: H04 -- Individual page numbers not listed on original publication -- Source: Wos |
